Revision history of "Inside vitro exercise involving cefiderocol versus ceftazidimeavibactam vulnerable as well as resilient KPCproducing Enterobacterales crossresistance and also synergistic effects"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 09:14, 13 May 2024Stoolseeder49 (Talk | contribs). . (3,575 bytes) (+3,575). . (Created page with "5C; >80% with 2C), quick charge/discharge capacity (146 mAh g-1 from 3C) and ideal efficiency (>99.92%). This specific overall performance is never reported by some othe...")